Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial

The Lancet - United Kingdom
doi 10.1016/s0140-6736(17)32346-2
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

A Human Trigeminovascular Biomarker for Antimigraine Drugs: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial With Sumatriptan

Cephalalgia
MedicineNeurology
2016English

Photodynamic Therapy for Dysplastic Barrett's Oesophagus: A Prospective, Double Blind, Randomised, Placebo Controlled Trial

Gut
Gastroenterology
2000English

Donepezil for Dementia in Parkinson's Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2005English

Bumetanide in Hypokalaemic Periodic Paralysis: A Randomised, Double-Blind, Placebo Controlled Phase II Clinical Trial With a Crossover Design

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2016English

Double-Blind, Randomized, Controlled, Crossover Trial of Pregabalin for Neurogenic Claudication

Neurology
Neurology
2014English

Transcranial Direct Current Stimulation in Parkinson's Disease Dementia: A Randomised Double-Blind Crossover Trial

Brain Stimulation
NeuroscienceNeurologyBiophysics
2017English

Oral Versus Intravenous High-Dose Methylprednisolone for Treatment of Relapses in Patients With Multiple Sclerosis (COPOUSEP): A Randomised, Controlled, Double-Blind, Non-Inferiority Trial

The Lancet
Medicine
2015English

Zileuton for Pruritus in Sjögren-Larsson Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial

Acta Dermato-Venereologica
DermatologyMedicine
2016English

Sildenafil Citrate as a Medical Expulsive Therapy for Distal Ureteric Stones: A Randomised Double-Blind Placebo-Controlled Study

Arab Journal of Urology
Urology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy